The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Motor/vocal tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability?
Abstract
The occurrence of abnormal movements or perserverative/compulsive behaviors was noted in 34 (76%) of a group of 45 hyperactive boys during a double-blind crossover treatment trial of methylphenidate and dextroamphetamine given in a wide range of doses. These adverse effects were often subtle and transient, and they usually occurred only on one drug. There was only one case where treatment was discontinued due to the severity of the tic the subject developed during his initial treatment phase. Dextroamphetamine tended to produce more compulsive behaviors, which were also more likely to resemble clinical obsessive-compulsive disorder (OCD), than did methylphenidate. Abnormal movements and compulsive behaviors tended to co-occur on methylphenidate only; no general "Tourette-OCD diathesis" was found for this population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“dopamine agonists acting on the basal ganglia can generate OCD‐like behaviors in both animals (Szechtman et al., 1998), and humans (Borcherding et al., 1990)”
From Obsessive-compulsive disorder: Etiology, neuropathology, and cognitive dysfunction (2023) · cites this paper as Borcherding et al., 1990
Citations
Cites
(1976) · Medical Entomology and Zoology · Cited by 8,899
Nonparametric statistics for the behavioral sciences
McGinn, L. C. (1957) · Journal of the Franklin Institute · doi:10.1016/0016-0032(57)90766-4 · Cited by 7,284
On Methods in the Analysis of Profile Data
Greenhouse, S. W., & Geisser, S. (1959) · Psychometrika · doi:10.1007/bf02289823 · Cited by 4,946
Normative data on Revised Conners Parent and Teacher Rating Scales
Goyette, C. H., Conners, C. K., & Ulrich, R. F. (1978) · Research on Child and Adolescent Psychopathology · doi:10.1007/bf00919127 · Cited by 1,728
Obsessive-Compulsive Disorder in Children and Adolescents
Swedo, S. E. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810040041007 · Cited by 817
Gilles de la Tourette's Syndrome and Obsessive-Compulsive Disorder
Pauls, D. L. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800120066013 · Cited by 573
Stimulant Medications Precipitate Tourette's Syndrome
Lowe, T. L. (1982) · JAMA · doi:10.1001/jama.1982.03320370043028 · Cited by 256
Berg, C. Z., Whitaker, A. H., Davies, M., Flament, M. F., & Rapoport, J. L. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198811000-00017 · Cited by 190
Self-citationGilles de la Tourette's Syndrome following Methylphenidate Administration
Golden, G. S. (1974) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1974.tb02715.x · Cited by 148
Tics Following Methylphenidate Administration
DENCKLA, M. B. (1976) · JAMA · doi:10.1001/jama.235.13.1349 · Cited by 136
Cited by
Sorted by citations
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Tourette syndrome, associated conditions and the complexities of treatment
Robertson, M. M. (2000) · Brain · doi:10.1093/brain/123.3.425 · Cited by 704
European clinical guidelines for hyperkinetic disorder ? first upgrade
Taylor, E., D�pfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., et al. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1002-x · Cited by 682
Dulcan, M. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199710001-00007 · Cited by 628
Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., Arnsten, A. F. T., Cohen, D. J., & Leckman, J. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1067 · Cited by 588
Voigt, R. G., Llorente, A. M., Jensen, C. L., Fraley, J. K., Berretta, M. C., & Heird, W. C. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.116050 · Cited by 365
Stein, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09620-4 · Cited by 352
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
Ferguson, J. H. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200002000-00018 · Cited by 321
Biederman, J., Melmed, R. D., Patel, A., McBurnett, K., Konow, J., Lyne, A., Scherer, N., & for the SPD503 Study Group (2008) · Pediatrics · doi:10.1542/peds.2006-3695 · Cited by 317
Contemporary assessment and pharmacotherapy of Tourette syndrome
Scahill, L., Erenberg, G., Berlin, C. M., Budman, C., Coffey, B. J., Jankovic, J., Kiessling, L., King, R. A., Kurlan, R., Lang, A., et al. (2006) · NeuroRX · doi:10.1016/j.nurx.2006.01.009 · Cited by 300
Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders?
Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90126-a · Cited by 294
Self-citationATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND COMORBIDITY
Spencer, T. J., Biederman, J., & Wilens, T. (1999) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70163-2 · Cited by 271
Brandon, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00281-0 · Cited by 259
Leonard, B. E., McCartan, D., White, J., & King, D. J. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.579 · Cited by 248
Drug-Induced Movement Disorders
Jiménez‐Jiménez, F. J., Ruiz, P., & Molina, J. A. (1997) · Drug Safety · doi:10.2165/00002018-199716030-00004 · Cited by 227
Physiology of Basal Ganglia Disorders: An Overview
Hallett, M. (1993) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100047909 · Cited by 215
King, R. A., Leonard, H., & March, J. S. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199810001-00003 · Cited by 199
Rendleman, R. L., & Walkup, J. T. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00049-4 · Cited by 197
Graham, J., & Coghill, D. (2008) · CNS Drugs · doi:10.2165/00023210-200822030-00003 · Cited by 185
Leonard, H. L., Ale, C. M., Freeman, J. B., Garcia, A. M., & Ng, J. (2005) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.06.002 · Cited by 172
Wilens, T., & Spencer, T. (2000) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30108-1 · Cited by 180
Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder
Denys, D. A. J. P., de Vries, F., Cath, D. C., Figee, M., Vulink, N. C. C., Veltman, D. J., van der Doef, T. F., Boellaard, R., Westenberg, H. G. M., van Balkom, A. J. L. M., et al. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.012 · Cited by 171
Gadow, K. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950180030005 · Cited by 168
Methyiphenidate vs. amphetamine: Comparative review
Arnold, L. E. (2000) · Journal of Attention Disorders · doi:10.1177/108705470000300403 · Cited by 164
Yoga as an Intervention for Children With Attention Problems
Peck, H. L., Kehle, T. J., Bray, M. A., & Theodore, L. A. (2005) · School Psychology Review · doi:10.1080/02796015.2005.12086295 · Cited by 153
Thienemann, M., Murphy, T., Leckman, J., Shaw, R., Williams, K., Kapphahn, C., Frankovich, J., Geller, D., Bernstein, G., Chang, K., et al. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0145 · Cited by 149
Self-citationCerebrospinal Fluid Neurochemistry in Children and Adolescents With Obsessive-Compulsive Disorder
Swedo, S. E. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820010029004 · Cited by 149
Clinical guidelines for hyperkinetic disorder
Taylor, E. A., Sergeant, J. A., Döepfner, M., Gunning, B. W., Overmeyer, S., Möbius, H. J., & Eisert, H. G. (1998) · European Child & Adolescent Psychiatry · doi:10.1007/s007870050067 · Cited by 149
M. Robertson*, M. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0505-z · Cited by 143
Posey, D. J., Aman, M. G., McCracken, J. T., Scahill, L., Tierney, E., Arnold, L. E., Vitiello, B., Chuang, S. Z., Davies, M., Ramadan, Y., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.028 · Cited by 131
Law, S., & Schachar, R. J. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199908000-00009 · Cited by 130
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Punja, S., Shamseer, L., Hartling, L., Urichuk, L., Vandermeer, B., Nikles, J., & Vohra, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009996.pub2 · Cited by 122
Carlsson, M. L. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00146-9 · Cited by 121
Methylphenidate and its Isomers
Heal, D. J., & Pierce, D. M. (2006) · CNS Drugs · doi:10.2165/00023210-200620090-00002 · Cited by 119
Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder
Figee, M., de Koning, P., Klaassen, S., Vulink, N., Mantione, M., van den Munckhof, P., Schuurman, R., van Wingen, G., van Amelsvoort, T., Booij, J., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.021 · Cited by 112
Childhood Hyperactivity and Psychostimulants: A Review of Extended Treatment Studies
Schachar, R. J., & Tannock, R. (1993) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1993.3.81 · Cited by 112
Obsessive-compulsive disorder: Etiology, neuropathology, and cognitive dysfunction
Jalal, B., Chamberlain, S. R., & Sahakian, B. J. (2023) · Brain and Behavior · doi:10.1002/brb3.3000 · Cited by 111
The 4-Year Course of Tic Disorders in Boys With Attention-Deficit/Hyperactivity Disorder
Spencer, T. J., Biederman, J., Coffey, B. J., GELLER, D. A., Wilens, T. E., & Faraone, S. V. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.842 · Cited by 109
A neuro-evolutionary approach to the anxiety disorders
Stein, D. J., & Bouwer, C. (1997) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(97)00019-4 · Cited by 100
Erenberg, G. (2005) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2005.12.003 · Cited by 98
Gadow, K. D., Nolan, E. E., & Sverd, J. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199205000-00012 · Cited by 90
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Rasmussen, P. D., Huus, C.-M. L., Zwi, M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub3 · Cited by 118
Zike, I. D., Xu, T., Hong, N., & Veenstra-VanderWeele, J. M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.09.012 · Cited by 83
Tics and Dyskinesias Associated With Stimulant Treatment in Attention-Deficit Hyperactivity Disorder
Lipkin, P. H. (1994) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1994.02170080089017 · Cited by 83
McDougall, S. A., Collins, R. L., Karper, P. E., Watson, J. B., & Crawford, C. A. (1999) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.7.3.208 · Cited by 73
Elia, J., Welsh, P. A., Gulotta, C. S., & RAPOPORT, J. L. (1993) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1993.tb01071.x · Cited by 71
Self-citationFirst-onset tics in patients with attention-deficit–hyperactivity disorder: impact of stimulants
Roessner, V., Robatzek, M., Knapp, G., Banaschewski, T., & Rothenberger, A. (2006) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162206001290 · Cited by 70
Emergence of Tics in Children with ADHD: Impact of Once-Daily OROS® Methylphenidate Therapy
Palumbo, D., Spencer, T., Lynch, J., Co-Chien, H., & Faraone, S. V. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041649138 · Cited by 67
Nolan, E. E., & Gadow, K. D. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199705000-00009 · Cited by 66
New developments in childhood affective and anxiety disorders
Swedo, S. E., Leonard, H. L., & Allen, A. J. (1994) · Current Problems in Pediatrics · doi:10.1016/0045-9380(94)90023-x · Cited by 60
The Pharmacologic Treatment of Tic Disorders
Chappell, P. B., Leckman, J. F., & Riddle, M. A. (1995) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30457-7 · Cited by 60
Pediatric Psychopharmacotherapy: A Review of Recent Research
Gadow, K. D. (1992) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1992.tb00861.x · Cited by 57
METHYLPHENIDATE-INDUCED OBSESSIVE-COMPULSIVENESS
Kouris, S. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199802000-00001 · Cited by 50
Golub, M. S., Costa, L. G., Crofton, K. M., Frank, D. A., Fried, P. A., Gladen, B. C., Henderson, R. F., Liebelt, E. L., Lusskin, S. I., Marty, S., et al. (2005) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20048 · Cited by 49
Varley, C. K., Vincent, J., Varley, P., & Calderon, R. (2001) · Comprehensive Psychiatry · doi:10.1053/comp.2001.23145 · Cited by 46
Gürkan, K., Bi̇lgi̇ç, A., Türkoğlu, S., Kılıç, B. G., Aysev, A., & Uslu, R. I. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109348172 · Cited by 45
Drug Treatment for Hyperactive Children
Elia, J. (1993) · Drugs · doi:10.2165/00003495-199346050-00006 · Cited by 44
Self-citationMethylphenidate for the Treatment of Parkinson Disease and Other Neurological Disorders
Auriel, E., Hausdorff, J. M., & Giladi, N. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318170576c · Cited by 40
Neuropsychological Effects of Stimulant Medication on Children’s Learning and Behavior
Brown, R. T., & Borden, K. A. (1989) · Critical issues in neuropsychology · doi:10.1007/978-1-4899-6807-4_24 · Cited by 39
Psychostimulants in the treatment of children diagnosed with ADHD: Risks and mechanism of action
Breggin, P. R. (1999) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-1999-177 · Cited by 38
Drug and non-drug treatments of children with ADHD and tic disorders
Poncin, Y., Sukhodolsky, D. G., McGuire, J., & Scahill, L. (2007) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-007-1010-8 · Cited by 37
Animal models of obsessive compulsive disorder: recent findings and future directions
Hoffman, K. L. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.577772 · Cited by 39
ATTENTION DEFICIT HYPERACTIVITY DISORDER IN THE PRESENCE OF TOURETTE SYNDROME
Fréeman, R. D. (1997) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70322-4 · Cited by 36
Stereotyped Behavior: Effects of d-Amphetamine and Methylphenidate in the Young Rat
Roffman, J. L., & Raskin, L. A. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00321-3 · Cited by 35
Dificuldades no diagnóstico de TDAH em crianças
de Souza, I. G. S., Serra-Pinheiro, M. A., Fortes, D., & Pinna, C. M. D. S. (2007) · Jornal Brasileiro de Psiquiatria · doi:10.1590/s0047-20852007000500004 · Cited by 31
Effects of deep brain stimulation on prepulse inhibition in obsessive-compulsive disorder
Kohl, S., Gruendler, T. O. J., Huys, D., Sildatke, E., Dembek, T. A., Hellmich, M., Vorderwulbecke, M., Timmermann, L., Ahmari, S. E., Klosterkoetter, J., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.171 · Cited by 30
Clinical Pharmacology of Comorbid Attention Deficit Hyperactivity Disorder in Tourette Syndrome
Rizzo, R., & Gulisano, M. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-411546-0.00014-7 · Cited by 30
NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of methylphenidate
Golub, M. S., Costa, L. G., Crofton, K. M., Frank, D. A., Fried, P. A., Gladen, B. C., Henderson, R. F., Liebelt, E. L., Lusskin, S. I., Marty, S., et al. (2005) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20049 · Cited by 28
STIMULANT USE AND TRICHOTILLOMANIA
Martín, A., Scahill, L. D., Vitulano, L. A., & King, R. A. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199804000-00009 · Cited by 28
Arnold, P. D., Ickowicz, A., Chen, S., & Schachar, R. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000111 · Cited by 27
Pozzi, M., Carnovale, C., Mazhar, F., Peeters, G. G. A. M., Gentili, M., Nobile, M., Radice, S., & Clementi, E. (2019) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001058 · Cited by 27
An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
Boon‐yasidhi, V., Kim, Y. S., & Scahill, L. D. (2005) · PubMed · Cited by 26
Hoffman, K. L., & Morales, R. I. R. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.041 · Cited by 26
The Rights of Children and Parents In Regard to Children Receiving Psychiatric Diagnoses and Drugs
Breggin, P. R. (2014) · Children & Society · doi:10.1111/chso.12049 · Cited by 27
Kreilaus, F., Chesworth, R., Eapen, V., Clarke, R. A., & Karl, T. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112057 · Cited by 23
Tourette’s Syndrome and Obsessive Compulsive Disorder: Clinical Aspects
Steingard, R. J., & Dillon-Stout, D. (1992) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30213-2 · Cited by 24
Pharmacologic Treatment of Tic Disorders
Scahill, L. D., Chappell, P. B., King, R. A., & Leckman, J. F. (2000) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30137-8 · Cited by 24
MEDICAL AND SURGICAL TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER
Rapoport, J. L., & Inoff‐Germain, G. (1997) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70323-6 · Cited by 23
Self-citationJalal, B., McNally, R. J., Elias, J. A., Potluri, S., & Ramachandran, V. S. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00414 · Cited by 23
Safety of stimulant treatment in attention deficit hyperactivity disorder: part II
Merkel, R. L. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2010.503238 · Cited by 21
Drug Class Review on Pharmacologic Treatments for ADHD
McDonagh, M. S., Peterson, K., & Thakurta, S. (2005) · Cited by 21
Methylphenidate-induced obsessive-compulsive symptoms: A case report and review of literature
Grover, S., Jhanda, S., & Singla, N. (2016) · Journal of Pediatric Neurosciences · doi:10.4103/1817-1745.199461 · Cited by 20
The Neurobiology of Obsessive-Compulsive Disorder
Stein, D. J. (1996) · The Neuroscientist · doi:10.1177/107385849600200516 · Cited by 20
Niederhofer, H., Staffen, W., & Mair, A. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017001714 · Cited by 20
RetractedPharmacotherapy of Obsessive-Compulsive Disorder
March, J. S., Leonard, H. L., & Swedo, S. E. (1995) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30458-9 · Cited by 20
Weight Gain and Antipsychotic Medications
Aquila, R., & Emanuel, M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0512a · Cited by 19
Schmidt, M. E., Kruesi, M. J. P., Elia, J., Borcherding, B. G., Elin, R. J., Hosseini, J. M., McFarlin, K. E., & Hamburger, S. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90007-8 · Cited by 18
Self-citationLeonard, H. L., Lenane, M., & Swedo, S. E. (1993) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30531-5 · Cited by 18
Gilles de la Tourette syndrome: A neuropsychiatric disorder
Sandor, P. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90030-j · Cited by 17
Breggin, P. R. (2000) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-2000-208 · Cited by 16
Pillidge, K., Porter, A. J., Young, J. W., & Stanford, S. C. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116642541 · Cited by 17
The Assessment and Coordination of Treatment of Children and Adolescents with OCD
King, R. A., & Scahill, L. D. (1999) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30169-x · Cited by 15
Psychotherapy and medication management strategies for obsessive-compulsive disorder
Walsh, K. H., & McDougle (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s13205 · Cited by 15
Scahill, L. D., Barloon, L. F., & Farkas, L. (1999) · Journal of Child and Adolescent Psychiatric Nursing · doi:10.1111/j.1744-6171.1999.tb00065.x · Cited by 13
Leonard, H. L., Swedo, S. E., Allen, A. J., & Rapoport, J. L. (1994) · Issues in clinical child psychology · doi:10.1007/978-1-4899-1498-9_11 · Cited by 13
Self-citationPsilocybin in pharmacotherapy of obsessive-compulsive disorder
Owe-Larsson, M., Kamińska, K., Buchalska, B., Mirowska-Guzel, D. M., & Cudnoch‐Jędrzejewska, A. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00633-1 · Cited by 13
Murphy, T. K., Frazier, S., & Kim, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-252-6_10 · Cited by 11
Socio‐emotional well‐being benefits of yoga for atypically developing children
Laxman, K. (2022) · Journal of Research in Special Educational Needs · doi:10.1111/1471-3802.12556 · Cited by 10
Methylphenidate Induced Obsessive-Compulsive Symptoms Treated with Sertraline
Coşkun, M. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20110904061403 · Cited by 10
Metadata
- Authors
- Borcherding, B. G., Keysor, C. S., Rapoport, J. L., Elia, J., & Amass, J.
- Affiliations
- National Institute of Mental Health (US)
- National Institutes of Health (US)
- Corresponding author
- Rapoport, Judith L.
- ORCID
- Elia, Josephine
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 1990-07
- Volume
- 33
- Issue
- 1
- Pages
- 83-94
- ISSN
- 0165-1781 (ISSN-L)
- OpenAlex
- W1978755811
- Cited by
- 150
- References
- 27
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 5 · 2022: 6 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 1 · 2016: 8 · 2015: 4 · 2014: 2 · 2013: 3 · 2012: 2
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychiatry Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- motor tics, vocal tics, compulsive behavior, stimulant side effects, methylphenidate, d-amphetamine, hyperactive children, Tourette syndrome, obsessive-compulsive disorder, perseveration
- MeSH terms
- Attention Deficit Disorder with Hyperactivity, Child, Compulsive Behavior, Dextroamphetamine, Double-Blind Method, Tourette Syndrome, Humans, Male, Methylphenidate, Motor Activity, Neurologic Examination, Obsessive-Compulsive Disorder, Risk Factors, Stereotyped Behavior, Tic Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review